Abstract
Background
Sacrococcygeal teratoma (SCT) is a rare childhood malignancy. Although overall survival is favorable, recurrent tumors are associated with poor outcomes. As most recurrences occur within 3 years of presentation, the utility of long-term surveillance is uncertain.
Methods
Patients with SCTs evaluated and managed by our pediatric surgery department between 1986 and 2013 were included. Details pertaining to laboratory values, operative findings, tumor histology, management, recurrence, and outcomes were recorded and analyzed.
Results
During the study period, 40 children with the diagnosis of SCT were managed by our practice. Five (13%) developed a recurrence. The median age at the initial resection was day of life two (range day of life 0–2.5 years). The median time to recurrence was 5 years (range 5 months–15 years). Among those with recurrences, mature teratoma was the most common histological type on the initial resection (n = 3), with yolk sac and immature teratomas comprising the other two. At the time of recurrence, three patients had mature teratomas, and all are alive and well following resection. Two patients had yolk sac tumors at the time of recurrence and both died.
Conclusion
SCT can recur many years after the initial resection. Our findings suggest that all patients with SCT should be closely followed into adulthood.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Winderl LM, Silverman RK (1997) Prenatal identification of a completely cystic internal sacrococcygeal teratoma (type iv). Ultrasound Obstet Gynecol 9:425–428
Huddart SN, Mann JR, Robinson K et al (2003) Sacrococcygeal teratomas: the uk children’s cancer study group’s experience. I Neonatal Pediatr Surg Int 19:47–51
Izant RJ Jr, Filston HC (1975) Sacrococcygeal teratomas. Analysis of forty-three cases. Am J Surg 130:617–621
Gobel U, Schneider DT, Calaminus G et al (2001) Multimodal treatment of malignant sacrococcygeal germ cell tumors: a prospective analysis of 66 patients of the german cooperative protocols MAKEI 83/86 and 89. J Clin Oncol 19:1943–1950
Mann JR, Raafat F, Robinson K et al (1998) UKCCSG's germ cell tumour (GCT) studies: improving outcome for children with malignant extracranial non-gonadal tumours–carboplatin, etoposide, and bleomycin are effective and less toxic than previous regimens. United Kingdom Children’s Cancer Study Group. Med Pediatr Oncol 30:217–227
Makin EC, Hyett J, Ade-Ajayi N et al (2006) Outcome of antenatally diagnosed sacrococcygeal teratomas: single-center experience (1993–2004). J Pediatr Surg 41:388–393
Derikx JP, De Backer A, van de Schoot L et al (2006) Factors associated with recurrence and metastasis in sacrococcygeal teratoma. Br J Surg 93:1543–1548
Rescorla FJ, Sawin RS, Coran AG et al (1998) Long-term outcome for infants and children with sacrococcygeal teratoma: a report from the childrens cancer group. J Pediatr Surg 33:171–176
Shue E, Bolouri M, Jelin EB et al (2013) Tumor metrics and morphology predict poor prognosis in prenatally diagnosed sacrococcygeal teratoma: a 25-year experience at a single institution. J Pediatr Surg 48:1225–1231
De Backer A, Madern GC, Hakvoort-Cammel FG et al (2006) Study of the factors associated with recurrence in children with sacrococcygeal teratoma. J Pediatr Surg 41:173–181 (discussion 173–181)
Marina NM, Cushing B, Giller R et al (1999) Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: a pediatric oncology group/children’s cancer group intergroup study. J Clin Oncol 17:2137–2143
Yao W, Li K, Zheng S et al (2014) Analysis of recurrence risks for sacrococcygeal teratoma in children. J Pediatr Surg 49:1839–1842
Partridge EA, Canning D, Long C et al (2014) Urologic and anorectal complications of sacrococcygeal teratomas: prenatal and postnatal predictors. J Pediatr Surg 49:139–142 (discussion 142–133)
Blohm ME, Vesterling-Horner D, Calaminus G, Gobel U (1998) Alpha 1-fetoprotein ((AFP)) reference values in infants up to 2 years of age. Pediatr Hematol Oncol 15:135–142
Gabra HO, Jesudason EC, McDowell HP et al (2006) Sacrococcygeal teratoma–a 25-year experience in a UK regional center. J Pediatr Surg 41:1513–1516
Lahdenne P, Heikinheimo M, Nikkanen V et al (1993) Neonatal benign sacrococcygeal teratoma may recur in adulthood and give rise to malignancy. Cancer 72:3727–3731
Ho KO, Soundappan SV, Walker K et al (2011) Sacrococcygeal teratoma: the 13-year experience of a tertiary paediatric centre. J Pediatr Child Health 47:287–291
Mann JR, Gray ES, Thornton C et al (2008) Mature and immature extracranial teratomas in children: the UK children's cancer study group experience. J Clin Oncol 26:3590–3597
Graves CE, Idowu O, Zovickian J, Pang D, Kim S (2017) Use of intraoperative lateral pelvic x-ray to localize and ensure coccyx removal during sacrococcygeal teratoma resection. Pediatr Surg Int 33:389–392
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Padilla, B., Vu, L., Lee, H. et al. Sacrococcygeal teratoma: late recurrence warrants long-term surveillance. Pediatr Surg Int 33, 1189–1194 (2017). https://doi.org/10.1007/s00383-017-4132-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-017-4132-1